🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
This was a Phase III, Efficacy and Safety Study of Oleogel-S10 in Participa...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2017-03-29
Trial ID
NCT03068780
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pimecroli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-12
Trial ID
NCT00510003
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of twice dai...
Status
Completed
Location
Cahaba Dermatology
Start Date
2018-12-20
Trial ID
NCT03745638
Treatments Being Tested
The purpose of this study is to determine if 0.5% Ivermectin Cream is a saf...
Status
Completed
Location
Arkansas Pediatric Clinic
Start Date
2010-03
Trial ID
NCT01068158
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02235272
This Phase III study is designed to evaluate the efficacy and safety of KX2...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-09-18
Trial ID
NCT03285477
Treatments Being Tested
This is a phase 2 study to investigate the safety and efficacy of PAC-14028...
Status
Completed
Location
Chung-ang University Hospital
Start Date
2015-10
Trial ID
NCT02757729
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested